半乳糖凝集素-3在银屑病亚临床心肌损害中的作用
本研究纳入102例银屑病患者与65名年龄性别匹配的健康对照,评估半乳糖凝集素-3(Gal-3)与左心室收缩舒张功能的关系。银屑病患者Gal-3、ESR、CRP升高且整体纵向应变(GLS)降低,GLS与Gal-3、ESR等独立相关,ESR与GLS的关系部分由Gal-3介导。
要点
- 银屑病患者Gal-3、ESR、CRP高于健康对照,GLS低于健康对照。
- GLS随Gal-3三分位升高呈进行性恶化。
- 银屑病患者GLS的独立决定因素为Gal-3和ESR。
核心结论
- 银屑病亚临床左心室收缩功能障碍(表现为GLS降低)与炎症上调相关,血清Gal-3升高反映的促纤维化活性增强可能参与该过程。
- 这些推测机制可能解释该病中观察到的心力衰竭发生率较高,并应被视为预防和治疗措施的潜在靶点。
研究设计与样本
- 研究纳入102例银屑病患者(平均年龄52.5±12.6岁),65名年龄和性别匹配的健康受试者作为对照。
- 超声心动图评估心肌功能包括左心室纵向收缩形变(GLS)及舒张指标:组织e'速度和E/e'比值。
- 实验室检测包括血Gal-3、肌酐、葡萄糖、胰岛素、CRP和红细胞沉降率(ESR)。
主要发现
- 银屑病患者Gal-3为12.3 [9.3-13.4] ng/mL,健康对照为6.3 [5.5-9.4] ng/mL,P < 0.001。
- 银屑病患者ESR为17.0 [11.0-29.0] mm,健康对照为8.5 [6.0-13.0] mm,P < 0.001。
- 银屑病患者CRP为3.1 [1.7-10.6] mg/L,健康对照为1.9 [1.5-4.0] mg/L,P < 0.001。
- 银屑病患者GLS为19.9±3.7%,健康对照为22.0±3.0%,P < 0.001。
- GLS与年龄(beta = -0.21,P < 0.04)、Gal-3(beta = -0.27,P < 0.01)、CRP(beta = -0.22,P < 0.03)、ESR(beta = -0.25,P < 0.01)、腰围(beta = -0.22,P < 0.03)和腰臀比(beta = -0.20,P < 0.05)存在显著关联。
关键数值与推荐
- 逐步多元回归分析显示,银屑病患者GLS的独立决定因素为Gal-3(beta = -0.24,P < 0.01)和ESR(beta = -0.21,P < 0.03)。
- 基于回归的中介分析表明,ESR与GLS之间的关系部分由Gal-3介导。
- GLS随Gal-3三分位升高呈进行性恶化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psoriasis has been shown to increase cardiovascular risk, and a contributor to this might be enhanced myocardial fibrosis promoted by the disease-associated pro-inflammatory milieu. OBJECTIVE: We sought to investigate the relationship of galectin-3 (Gal-3) - a recognized mediator of fibrosis with inflammatory activation and left ventricular (LV) systolic and diastolic function in patients with psoriasis. METHODS: We enrolled 102 psoriatic patients (mean age: 52.5 ± 12.6 years). Sixty-five age- and sex-matched healthy subjects served as controls. Echocardiographic assessment of myocardial function included estimation of LV longitudinal systolic deformation (GLS) and diastolic indices: tissue e' velocity and E/e' ratio. Laboratory measurements encompassed blood Gal-3, creatinine, glucose, insulin, CRP and erythrocyte sedimentation rate (ESR). RESULTS: Patients with psoriasis were characterized by elevated Gal-3 (12.3 [9.3-13.4] vs. 6.3 [5.5-9.4] ng/mL in healthy controls, P < 0.001), ESR (17.0 [11.0-29.0] vs. 8.5 [6.0-13.0] mm, respectively, P < 0.001) and CRP (3.1 [1.7-10.6] vs. 1.9 [1.5-4.0] mg/L, respectively, P < 0.001), and reduced GLS (19.9 ± 3.7 vs. 22.0 ± 3.0%, respectively, P < 0.001). Progressive deterioration of GLS was demonstrated across Gal-3 tertiles. Significant associations between GLS and age (beta = -0.21, P < 0.04), Gal-3 (beta = -0.27, P < 0.01), CRP (beta = -0.22, P < 0.03), ESR (beta = -0.25, P < 0.01), waist circumference (beta = -0.22, P < 0.03) and waist-to-hip ratio (beta = -0.20, P < 0.05) were found. Stepwise multiple regression analysis revealed that the independent determinants of GLS in psoriatic patients were Gal-3 (beta = -0.24, P < 0.01) and ESR (beta = -0.21, P < 0.03). Regression-based mediation analysis demonstrated that the relationship between ESR and GLS was partially mediated by Gal-3. CONCLUSIONS: Subclinical left ventricular systolic dysfunction in psoriasis, as evidenced by reduced GLS, is linked with the inflammatory upregulation, and enhanced profibrotic activity (as reflected by elevated serum Gal-3) may be involved in this process. These putative mechanisms may be responsible for the observed higher incidence of heart failure in this disease condition and should be considered as a potential target for preventive and therapeutic measures.
引用
- Kotwica T, Relewicz J, Rojek A, et al. Role of galectin-3 in subclinical myocardial impairment in psoriasis. J Eur Acad Dermatol Venereol. 2018. PMID: 30098067. doi:10.1111/jdv.15211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。